Dov Tamarkin
Director/Board Member at RAY TLV GROUP LTD
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Lior Wayn | M | 51 |
Mica Artificial Intelligence Ltd.
 Mica Artificial Intelligence Ltd. Packaged SoftwareTechnology Services Mica Artificial Intelligence Ltd. is a company based in Tel Aviv, Israel that aims to save lives and improve the quality of life by decreasing the number of breast cancer cases by one-third. The Israeli company's commitment to the United Nations Sustainable Development Goals is reflected in their approach to the environmental and social dimensions. Mica's mission is to make yearly checkups and follow-ups less challenging. Mica's innovative system, DENISE, is an AI-based algorithm that provides decision-support to radiologists and was developed and validated at the SHEBA Hospital. The system showed an increase in the classification of contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. The company was founded by Lilia Shwartsman, Rony Weitzen, Lior Wayn, and Dov Tamarkin, with Lior Wayn serving as the CEO since incorporation. | - |
| Balfour Mor | M | 70 | 42 years | |
| Mitchell Shirvan | M | 70 |
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 10 years |
| Sarit Saban Shalit | F | 54 | 4 years | |
| Mutya Harsch | F | 50 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 6 years |
| Ori Weiss | M | 48 | 6 years | |
| Toshav Boaz | M | 47 | 6 years | |
| Dan Lallouz | M | 58 | 2 years | |
| Elijah Weiss | M | - | 42 years | |
| Rony Weitzen | M | - |
Mica Artificial Intelligence Ltd.
Mica Artificial Intelligence Ltd. Packaged SoftwareTechnology Services Mica Artificial Intelligence Ltd. is a company based in Tel Aviv, Israel that aims to save lives and improve the quality of life by decreasing the number of breast cancer cases by one-third. The Israeli company's commitment to the United Nations Sustainable Development Goals is reflected in their approach to the environmental and social dimensions. Mica's mission is to make yearly checkups and follow-ups less challenging. Mica's innovative system, DENISE, is an AI-based algorithm that provides decision-support to radiologists and was developed and validated at the SHEBA Hospital. The system showed an increase in the classification of contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. The company was founded by Lilia Shwartsman, Rony Weitzen, Lior Wayn, and Dov Tamarkin, with Lior Wayn serving as the CEO since incorporation. | - |
| Lilia Shwartsman | F | - |
Mica Artificial Intelligence Ltd.
Mica Artificial Intelligence Ltd. Packaged SoftwareTechnology Services Mica Artificial Intelligence Ltd. is a company based in Tel Aviv, Israel that aims to save lives and improve the quality of life by decreasing the number of breast cancer cases by one-third. The Israeli company's commitment to the United Nations Sustainable Development Goals is reflected in their approach to the environmental and social dimensions. Mica's mission is to make yearly checkups and follow-ups less challenging. Mica's innovative system, DENISE, is an AI-based algorithm that provides decision-support to radiologists and was developed and validated at the SHEBA Hospital. The system showed an increase in the classification of contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. The company was founded by Lilia Shwartsman, Rony Weitzen, Lior Wayn, and Dov Tamarkin, with Lior Wayn serving as the CEO since incorporation. | - |
| Doron Lev Rozenblum | M | 54 | 6 years | |
| Haim Weiss | M | - | - | |
| Jacob Peri | M | - |
Mica Artificial Intelligence Ltd.
Mica Artificial Intelligence Ltd. Packaged SoftwareTechnology Services Mica Artificial Intelligence Ltd. is a company based in Tel Aviv, Israel that aims to save lives and improve the quality of life by decreasing the number of breast cancer cases by one-third. The Israeli company's commitment to the United Nations Sustainable Development Goals is reflected in their approach to the environmental and social dimensions. Mica's mission is to make yearly checkups and follow-ups less challenging. Mica's innovative system, DENISE, is an AI-based algorithm that provides decision-support to radiologists and was developed and validated at the SHEBA Hospital. The system showed an increase in the classification of contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. The company was founded by Lilia Shwartsman, Rony Weitzen, Lior Wayn, and Dov Tamarkin, with Lior Wayn serving as the CEO since incorporation. | - |
| Ilanit Halperin | F | 53 | 5 years | |
| Liron Levy | F | - | - | |
| Elad Bibi | M | - | - | |
| Chen Amster | M | 40 | 2 years | |
| David Schuz | M | 69 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 18 years |
| Chaim Chizic | M | - |
Mica Artificial Intelligence Ltd.
Mica Artificial Intelligence Ltd. Packaged SoftwareTechnology Services Mica Artificial Intelligence Ltd. is a company based in Tel Aviv, Israel that aims to save lives and improve the quality of life by decreasing the number of breast cancer cases by one-third. The Israeli company's commitment to the United Nations Sustainable Development Goals is reflected in their approach to the environmental and social dimensions. Mica's mission is to make yearly checkups and follow-ups less challenging. Mica's innovative system, DENISE, is an AI-based algorithm that provides decision-support to radiologists and was developed and validated at the SHEBA Hospital. The system showed an increase in the classification of contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. The company was founded by Lilia Shwartsman, Rony Weitzen, Lior Wayn, and Dov Tamarkin, with Lior Wayn serving as the CEO since incorporation. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Meir Eini | M | 69 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 14 years |
| Ilan Hadar | M | 55 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | - |
| David Domzalski | M | 58 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 6 years |
| Stanley Hirsch | M | 66 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 15 years |
| Avraham Sadan | M | 41 | 3 years | |
| Yohan Hazot | M | 41 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | - |
| Anna Kazanchyan | M | 55 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 6 years |
| Stanley Stern | M | 67 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 6 years |
| Darrell S. Rigel | M | 73 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 4 years |
| Rex Bright | M | 84 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 6 years |
| Aharon Schwartz | M | 80 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 5 years |
| Alvin D. Howard | M | 69 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | - |
| Dalia Megiddo | M | 72 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 3 years |
| Doron Pinhas Birger | M | 73 | 1 years | |
| Chaim Chizic | M | 74 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 7 years |
| Iain Stuart | M | 51 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | 4 years |
| Yael Fund-Gross | F | - |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | - |
| Yona Levy | M | 52 | 3 years | |
| Itay Rosenfeld | M | - | 1 years | |
| Elad Gazit | M | 47 | 4 years | |
| Eti Ester Langermann | F | 54 | 1 years | |
| Herman Ellman | M | 76 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | - |
| Nachshol Cohen | M | 42 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Israel | 43 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dov Tamarkin
- Personal Network
